financetom
Business
financetom
/
Business
/
GameStop Stock Is Surging Wednesday: What's Going On?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
GameStop Stock Is Surging Wednesday: What's Going On?
Mar 26, 2025 6:32 AM

GameStop Corp ( GME ) shares are trading higher Wednesday after the company reported fourth-quarter earnings and announced the approval of Bitcoin (CRYPTO: BTC) as a treasury reserve asset. Here’s a look at what you need to know.

Q4 Revenue: $1.283 billion, versus estimates of $1.48 billion

Q4 Adjusted EPS: 30 cents, versus estimates of 8 cents

Total revenue was down approximately 28% year-over-year. Hardware and accessories revenue totaled $725.8 million in the quarter, Software revenue was $286.2 million and Collectibles revenue came in at $270.6 million.

GameStop ( GME ) reported net income of $131.3 million in the fourth quarter, up from $63.1 million in the prior year's quarter. The video game retailer ended the quarter with approximately $4.78 billion in cash, cash equivalents and marketable securities.

GameStop ( GME ) also announced its board unanimously approved an update to its investment policy to include Bitcoin as a treasury reserve asset. The company said it plans to use a portion of its cash or future debt and equity issuances to invest in Bitcoin.

“We have not set a maximum amount of Bitcoin we may accumulate, and may sell any Bitcoin we may acquire,” the company said in a filing.

Check This Out: Jim Cramer Applauds GameStop For Acting On His ‘Bitcoin Ploy,’ CEO Ryan Cohen Can’t Help But React

GameStop ( GME ) previously made a push into the crypto space with the launch of wallets that let users manage crypto and NFTs. The company closed down the offering in 2023 due to "regulatory uncertainty."

Continuing a trend from recent quarters, GameStop ( GME ) refrained from holding a conference call with investors to discuss its quarterly performance and outlook. The company noted that it plans to continue to focus on establishing omnichannel retail excellence, cost containment and increased efficiency and expanding its addressable market.

Following the print, Wedbush’s Michael Pachter called GameStop ( GME ) "a rich man's MicroStrategy” in response to the company’s pivot towards Bitcoin.

“If GameStop were to buy all Bitcoin with their $4.6 billion in cash and trade at two times, the stock would drop five bucks,” the analyst said.

GME Price Action: GameStop ( GME ) shares were up 11.4% at $28.30 at the time of publication Wednesday, according to Benzinga Pro.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Delaware judge says she will not block Metsera from ending Pfizer deal 
Delaware judge says she will not block Metsera from ending Pfizer deal 
Nov 5, 2025
WILMINGTON, Delaware, Nov 5 (Reuters) - A Delaware judge said on Wednesday she would reject a request by Pfizer ( PFE ) to temporarily block Metsera ( MTSR ) from terminating its takeover deal with Pfizer ( PFE ), allowing Metsera ( MTSR ) to proceed instead with a higher $10 billion deal from Novo Nordisk. ...
World Kinect Corporation Completes Acquisition of Universal Weather and Aviation's Trip Support Services Business
World Kinect Corporation Completes Acquisition of Universal Weather and Aviation's Trip Support Services Business
Nov 5, 2025
MIAMI--(BUSINESS WIRE)-- World Kinect Corporation ( WKC ) today announced that it has completed its previously announced acquisition of the Trip Support Services (TSS) division of Universal Weather and Aviation. Universal Weather, headquartered in Houston, Texas, has been a pioneer in trip support services with deep expertise in international travel regulations, logistics, and supply chain management. Its trip support business...
Cardiac muscle therapeutics firm Cytokinetics Q3 net loss widens
Cardiac muscle therapeutics firm Cytokinetics Q3 net loss widens
Nov 5, 2025
Overview * Cytokinetics ( CYTK ) Q3 net loss widens to $306.2 mln, driven by debt conversion expense * Company reports Q3 revenue of $1.9 mln, up from $0.5 mln last year * Cytokinetics ( CYTK ) prepares for potential U.S. launch of aficamten pending FDA approval Outlook * Company expects EMA decision on aficamten MAA in 1H 2026 *...
Jazz Pharmaceuticals Q3 revenue beats estimates
Jazz Pharmaceuticals Q3 revenue beats estimates
Nov 5, 2025
Overview * Jazz Pharmaceuticals ( JAZZ ) Q3 revenue grows 7% yr/yr, beating analyst expectations * Adjusted EPS for Q3 beats consensus, reflecting robust operational performance * Company narrows 2025 revenue guidance to $4.175 - $4.275 bln Outlook * Company narrows 2025 revenue guidance to $4.175 - $4.275 bln * Jazz Pharmaceuticals ( JAZZ ) expects top-line data from zanidatamab...
Copyright 2023-2026 - www.financetom.com All Rights Reserved